This past Friday, on the sacred Jewish holiday Yom Kippur, Amy Mek, founder of RAIR Foundation USA, was contacted via Twitter by UK Sky News reporter Tom Cheshire (@Chesh).
His message suggested a forthcoming defamatory piece about her and her coverage of a vigil in Southport following the brutal, unprovoked stabbing and murder of six-year-old Bebe King, seven-year-old Elsie Dot Stancombe, nine-year-old Alice Dasilva Aguiar, and the serious wounding of multiple other victims.
These three innocent children were brutally stabbed to death during a Taylor Swift-themed class by 17-year-old Axel Rudakubana, who was born to Rwandan parents in Cardiff before moving to the village of Banks in Lancashire in 2013.
Amy’s public response to Tom Cheshire’s message aims to ensure transparency, allowing the public to see her statement and the facts of the situation. RAIR Foundation USA will update this post once Sky News publishes its article.
For context, Sky News is owned by Sky Group, which is a subsidiary of Comcast Corporation, a major American telecommunications company. […]
— Read More: rairfoundation.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
